Skip to content
Coming Soon·Opens soon·Synced from source July 6, 2026

NIAMS Clinical Trial Implementation Cooperative Agreement

National Institutes of Health

Posted
Jun 10, 2026
Amount
$250,000
Closes
No deadline published by the funder
Last verified
Jul 6, 2026

At a glance

This funding opportunity is offered by National Institutes of Health. Awards are up to $250,000.

Classification and identifiers

Solicitation number
PAR-28-031
Assistance listing (CFDA)
93.846

Amount

$250,000

Who can apply

NonprofitsHousing authoritiesCounty governmentsLocal governmentsPublic universitiesFor-profits

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

About this opportunity

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Clinical Trial Cooperative Agreement Program within the mission areas of the institute. This Notice of Funding Opportunity (NOFO) solicits cooperative agreement applications for implementation of investigator-initiated, single or multi-site, interventional clinical trials (all trial phases). Investigators who have completed all necessary preparation (e.g., the trial design, protocol synopsis, data analysis plan, etc.) through other means may apply for a NIAMS Cooperative Agreement Clinical Trial. The first phase is designed to allow the investigators to prepare the final aspects needed to start the trial, (e.g., establis...

Finding similar opportunities...